Oramed Pharmaceuticals
ORMP
#9104
Rank
HK$0.66 B
Marketcap
HK$16.33
Share price
-2.78%
Change (1 day)
-20.11%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): HK$0.19 Billion

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of HK$55.39 Million, an increase over its 2022 earnings that were of -HK$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$0.19 B247.71%
2023 HK$55.39 M-119.45%
2022 -HK$0.29 Billion39.17%
2021 -HK$0.21 Billion73.93%
2020 -HK$0.12 Billion18.53%
2019 -HK$99.25 Million-16.62%
2018 -HK$0.12 Billion38.32%
2017 -HK$86.06 Million12.51%
2016 -HK$76.49 Million25.01%
2015 -HK$61.19 Million18.18%
2014 -HK$51.78 Million39.72%
2013 -HK$37.06 Million46.4%
2012 -HK$25.32 Million128.32%
2011 -HK$11.09 Million-51.47%
2010 -HK$22.85 Million35.21%
2009 -HK$16.9 Million
2007 -HK$26.57 Million607.04%
2006 -HK$3.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$3.93 Billion-2,147.42%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$147.24 B 76,757.93%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
HK$61.74 B 32,128.38%๐Ÿ‡ซ๐Ÿ‡ท France
-HK$75.48 Million-139.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-HK$1.56 Billion-913.22%๐Ÿ‡บ๐Ÿ‡ธ USA